SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin’s arm recalling 2,724 bottles of Clomipramine hydrochloride Capsules

23 Apr 2025 Evaluate

Lupin’s arm -- Lupin Pharmaceuticals Inc. is recalling 2,724 bottles of Clomipramine hydrochloride Capsules USP, 25 mg in the US due to Failed Impurities/Degradation Specifications. This is an antidepressant medication which used in the treatment of obsessive-compulsive disorder. The company initiated the Class II recall on April 18, 2025.  

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2267.30 -110.60 (-4.65%)
11-May-2026 12:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1874.20
Dr. Reddys Lab 1295.65
Cipla 1314.50
Zydus Lifesciences 943.65
Lupin 2267.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×